Hypokalemia and salbutamol therapy in asthma

Pediatric Pulmonology

Volumn 27, Issue 1, 1999, Pages 27-31

  Hung, Chih Hsing ^a   Chu, Der Ming ^a   Wang, Chih Lu ^b   Yang, Kuender D ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b No 40 Sec 3 ^*

Author keywords

Bronchodilators; Hypokalemia; Peak expiratory flow; Salbutamol; Venous blood gases

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; HUMAN; HYPOKALEMIA; PEAK EXPIRATORY FLOW; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; VENOUS OXYGEN TENSION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; AGE FACTORS; ALBUTEROL; ASTHMA; BLOOD GAS ANALYSIS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; HYPOKALEMIA; INCIDENCE; MALE; PEAK EXPIRATORY FLOW RATE; RISK FACTORS; TREATMENT OUTCOME;

EID: 0032917796     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199901)27:1<27::AID-PPUL6>3.0.CO;2-P     Document Type: Article

References (30)

1. Noseda A, Yernaut JC. Sympathomimetics in acute severe asthma: inhaled or parental, nebulizer or parental, nebulizer or spacer? Eur Respir J 1989;2:377-382.
2. Robertson CF, Smith F, Beck R, Levison H. Response to frequent low dose of nebulized albuterol in acute asthma. J Pediatr 1985; 106:672-674.
3. Burgess CD, Flatt A, Siebers R, Crane J, Beasley R, Purdie G. A comparison of the extent and duration of hypokalemia following three nebulized beta 2-adrenoceptor agonists. Eur J Clin Pharmacol 1989;36:415-417.
4. Udezue E, D'Souza L, Mahajan M. Hypokalemia after normal doses of nebulized albuterol. Am J Emerg Med 1995;13:168-171.
5. Assadi FK. Therapy of acute bronchospasm - complicated by lactic acidosis and hypokalemia. Clin Pediatr (Phila) 1989;28:258-260.
6. Epelbaum S, Benhamou PH, Pautard JD, Devoldere C, Kremp O, Piussan C. Respiratory arrest in an asthmatic girl treated with beta 2-mimetics and theophylline - possible role of hypokalemia in sudden death in asthmatic patients. Ann Pediatr (Paris) 1989;36: 473-475.
7. Kolski GB, Cunningham AS, Niemec PW, Davignon GF, Freehafer JG. Hypokalemia and respiratory arrest in an infant with status asthmaticus. J Pediatr 1988;112:304-307.
8. Johnston RB, Schallor JG, Sly RM. Immunity, allergy, and disease of inflammation. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan VC, editors. Nelson textbook of pediatrics. Philadelphia: W.B. Saunders Co.; 1992, p 545-646.
9. Kerem E, Levison H, Schuh S, O'Brodovich H, Reisman J, Bentur L. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-317.
10. Long AP. Venous or arterial blood gas measurement. JAMA 1971;217:1706.
11. Williamson DC III, Edwin SM. Correlation of peripheral venous and arterial blood gas value during general anesthesia. Anesth Analg 1982;61:950-952.
12. O'Sullivan DD. Peripheral venous blood gas. JAMA 1971;217: 342.
13. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med 1986; 315:153-156.
14. Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax 1990; 45:170-175.
15. Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-1987: a further case-control study. Thorax 1991; 46:105-111.
16. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Bebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-506.
17. Wilson JD, Sutherland DC, Thomas AC. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet 1981;i:1235-1237.
18. Benatar SR. Fatal asthma. N Engl J Med 1986;314:423-429.
19. Dorin RI, Crano LM. Hypokalemic respiratory arrest in diabetic ketoacidosis. JAMA 1987;257:1517-1518.
20. McClure RJ, Prasad VK, Brocklebank JT. Treatment of hyperkalemia using intravenous and nebulized salbutamol. Arch Dis Child 1994;70:126-128.
21. Singhi SC, Jayashree K, Sarkar B. Hypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma. J Pediatr Child Health 1996;32:495-497.
22. Haffner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther 1992;17:155-164.
23. Sigguard-Andersen D, Gothgen IH. Oxygen and acid-base parameters of arterial and mixed venous blood, relevant versus redundant. Acta Anaesthesiol Scand 1995;107:21-27.
24. Knox AJ, Tattersfield AE. Airway smooth muscle relaxation. Thorax 1995;50:894-901.
25. Yuichi S, Yasui I, Tetsumi H, Takehiro I, Fukuko H, Hideaki K. Evaluation of a new beta-adrenoceptor agonist, procaterol, based on metabolic responses in rats. Biochem Pharmacol 1978;27: 2531-2535.
26. Miura M, Belvisi MG, Stretton CD, Yacoub MH, Barnes PJ. Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis 1992;146:132-136.
27. + ATPase activity in airway relaxation induced by salbutamol. Life Sci 1994;55:217-223.
28. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996;129:809-814.
29. 2+. J Clin Invest 1992;89:1988-1994.
30. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med 1994;96:63-76.